Follow the 메디톡스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 메디톡스 has logged 81 reports. Market capitalisation: €439.3bn. The latest transaction was disclosed on 2 April 2026 (Purchase). Among the most active insiders: 정현호. The full history is accessible without an account.
78
Insider Decl.
n/a
Thresholds
n/a
37 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 메디톡스 Hold (neutral), based on 4 analysts. Average price target: ₩99,500.
Fundamental score
Ranked 15,051 of 29,062 companies
51.0
score / 100
Value
49
Quality
53
FCF yld5.7%
Earn yld3.5%
EV/EBITDA20.2x
ROE3.6%
Gross mgn58%
Net mgn6.7%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Medytox es una empresa especializada en el sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de productos biofarmacéuticos.